These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 6969403

  • 21. dATP accumulation and ATP depletion in platelets in adenosine deaminase deficiency: significance for the immune response?
    Simmonds HA, Goday A, Morris GS, Fairbanks LD, Levinsky RJ.
    Biosci Rep; 1984 Oct; 4(10):809-18. PubMed ID: 6335053
    [Abstract] [Full Text] [Related]

  • 22. Deoxy-ATP accumulation in adenosine deaminase-inhibited human B and T lymphocytes.
    Gruber HE, Cohen AH, Firestein GS, Redelman D, Bluestein HG.
    Adv Exp Med Biol; 1986 Oct; 195 Pt A():503-7. PubMed ID: 3487921
    [No Abstract] [Full Text] [Related]

  • 23. Biochemical consequences of adenosine deaminase inhibition in vivo. Differential effects in acute and chronic T cell leukemia.
    Mitchell BS, Sidi Y, Hershfield M, Koller CA.
    Ann N Y Acad Sci; 1985 Oct; 451():129-37. PubMed ID: 3878114
    [No Abstract] [Full Text] [Related]

  • 24. Effects of 2'-deoxycoformycin on the metabolism of purines and the survival of malignant cells in a patient with T-cell leukemia.
    Yu AL, Bakay B, Kung FH, Nyhan WL.
    Cancer Res; 1981 Jul; 41(7):2677-82. PubMed ID: 6972800
    [Abstract] [Full Text] [Related]

  • 25. Deoxyadenosine triphosphate as a potentially toxic metabolite in adenosine deaminase deficiency.
    Cohen A, Hirschhorn R, Horowitz SD, Rubinstein A, Polmar SH, Hong R, Martin DW.
    Proc Natl Acad Sci U S A; 1978 Jan; 75(1):472-6. PubMed ID: 272665
    [Abstract] [Full Text] [Related]

  • 26. Inhibition of K and NK lymphocyte cytotoxicity by an inhibitor of adenosine deaminase and deoxyadenosine.
    Grever MR, Siaw MF, Coleman MS, Whisler RL, Balcerzak SP.
    J Immunol; 1983 Jan; 130(1):365-9. PubMed ID: 6600187
    [No Abstract] [Full Text] [Related]

  • 27. Inhibition of maturation of human precursor lymphocytes by coformycin, an inhibitor of the enzyme adenosine deaminase.
    Ballet JJ, Insel R, Merler E, Rosen FS.
    J Exp Med; 1976 May 01; 143(5):1271-6. PubMed ID: 1262787
    [Abstract] [Full Text] [Related]

  • 28. Formation and degradation of deoxyadenosine nucleotides in inherited adenosine deaminase deficiency.
    Simmonds HA, Webster DR, Perrett D, Reiter S, Levinsky RJ.
    Biosci Rep; 1982 May 01; 2(5):303-14. PubMed ID: 6980023
    [Abstract] [Full Text] [Related]

  • 29. The biochemical and clinical consequences of 2'-deoxycoformycin in refractory lymphoproliferative malignancy.
    Grever MR, Siaw MF, Jacob WF, Neidhart JA, Miser JS, Coleman MS, Hutton JJ, Balcerzak SP.
    Blood; 1981 Mar 01; 57(3):406-17. PubMed ID: 6970050
    [Abstract] [Full Text] [Related]

  • 30. Selective immunotoxic effects in mice treated with the adenosine deaminase inhibitor 2'-deoxycoformycin.
    Luebke RW, Lawson LD, Rogers RR, Riddle MM, Rowe DG, Smialowicz RJ.
    Immunopharmacology; 1987 Feb 01; 13(1):25-35. PubMed ID: 2952620
    [Abstract] [Full Text] [Related]

  • 31. Induction of DNA strand breaks in chronic lymphocytic leukemia following treatment with 2'-deoxycoformycin in vivo and in vitro.
    Begleiter A, Glazer RI, Israels LG, Pugh L, Johnston JB.
    Cancer Res; 1987 May 01; 47(9):2498-503. PubMed ID: 3494509
    [Abstract] [Full Text] [Related]

  • 32. Treatment of acute lymphoblastic leukemia with the adenosine deaminase inhibitor 2'-deoxycoformycin.
    Mitchell BS, Koller CA, Kelley WN.
    Adv Exp Med Biol; 1979 May 01; 122B():347-50. PubMed ID: 317568
    [No Abstract] [Full Text] [Related]

  • 33. The effects of ADA inhibition on B cell differentiation in the rat.
    Barton RW.
    Adv Exp Med Biol; 1986 May 01; 195 Pt A():525-9. PubMed ID: 3524140
    [No Abstract] [Full Text] [Related]

  • 34. Hypnotic effects of deoxycorformycin in rats.
    Radulovacki M, Virus RM, Djuricic-Nedelson M, Green RD.
    Brain Res; 1983 Jul 25; 271(2):392-5. PubMed ID: 6604561
    [Abstract] [Full Text] [Related]

  • 35. Effects of pentostatin (2'deoxycoformycin), an inhibitor of adenosine deaminase, on type II collagen-induced arthritis in rats.
    Gilbertsen RB.
    J Immunopharmacol; 1985 Jul 25; 7(3):325-41. PubMed ID: 3877119
    [Abstract] [Full Text] [Related]

  • 36. Adenosine deaminase in malaria infection: effect of 2'-deoxycoformycin in vivo.
    Webster HK, Wiesmann WP, Pavia CS.
    Adv Exp Med Biol; 1984 Jul 25; 165 Pt A():225-9. PubMed ID: 6609525
    [No Abstract] [Full Text] [Related]

  • 37. dATP-mediated inhibition of DNA ligase by 2'-deoxycoformycin in T and B cell leukemia.
    Lamballe F, Le Prise PY, Le Gall E, David JC.
    Leukemia; 1989 Feb 25; 3(2):97-103. PubMed ID: 2783473
    [Abstract] [Full Text] [Related]

  • 38. Potential use of purine nucleosides and enzyme inhibitors for selective depletion of Thy-lymphoblasts from human bone marrow.
    Russell NH, Hoffbrand AV, Bellingham AJ.
    Leuk Res; 1986 Feb 25; 10(3):325-9. PubMed ID: 3081767
    [Abstract] [Full Text] [Related]

  • 39. Effect of 2'-deoxycoformycin on the inhibition of deoxyribonucleic acid synthesis by 9-beta-D-arabinofuranosyladenine 5'-triphosphate.
    Shewach DS, Plunkett W.
    Biochem Pharmacol; 1982 Jun 01; 31(11):2103-9. PubMed ID: 6180754
    [No Abstract] [Full Text] [Related]

  • 40. Remission induction with adenosine-deaminase inhibitor 2'-deoxycoformycin in Thy-lymphoblastic leukaemia.
    Prentice HG, Smyth JF, Ganeshaguru K, Wonke B, Bradstock KF, Janossy G, Goldstone AH, Hoffbrand AV.
    Lancet; 1980 Jul 26; 2(8187):170-2. PubMed ID: 6105339
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.